Ferring Pharmaceuticals
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Ferring Pharmaceuticals
- Company name
- Ferring Pharmaceuticals
- Organisation type
- Industry
- Registered legal name
- FERRING PHARMACEUTICALS INC.
- Registry sponsor category
- Industry
- Website
- https://www.ferring.com/
- Legal Entity Identifier (LEI)
- 9845003H1F880CB0U143
- Wikidata ID
- Q686794
Related records
Trials (330)
- 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
- 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
- A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
- A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator
- A Clinical Trial to Evaluate Dichloroacetate (DCA) as a Treatment for Endometriosis-associated Pain
- A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel
- A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
- A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer
- A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US
- A Degarelix Trial in Patients With Prostate Cancer
- A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment
- A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment
- A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency
- A Long Term Safety Study of Degarelix in Patients With Prostate Cancer
- A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
- A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection
- A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
- A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer
- A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis